TOPRA conferences & networking events

TOPRA holds several high-level conferences and events annually, including our Annual Symposium in a different European city each year and our Annual Summit in London, to discuss issues of high importance to regulatory affairs professionals.

Download TOPRA's Courses & Conferences calendar for 2022 (PDF)

 

Conferences & special events

Begin DateTitleDescriptionCityCountry
There are no records.

 

TOPRA Special Interest Network (SPIN) events

Start dateTitleDescription
14/02/2023MedTech SPIN Webinar: EU-MDR New Rule 21In this webinar, Theresa Jeary will shed some light on rule 21, its intent and how manufacturers can develop an effective regulatory strategy to successfully navigate conformity assessments and ensure Annex I to Directive 2001/83/EC requirements are met.MEDTJAN23
08/03/2023TOPRA Fellows Presentation and DinnerTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency), followed by a three course dinner at a nearby hotel.FELMAR23
08/03/2023TOPRA Fellows Presentation and DinnerTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency), followed by a three course dinner at a nearby hotel.FELMAR23.2
08/03/2023TOPRA Fellows Presentation - OnlineTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency).FELMAR23OL

 

TOPRA In regional networking events

Start dateTitleDescriptionCityCountry
14/02/2023TOPRA in Sweden: Medical Devices-Combination ProductsThis evening is an excellent opportunity to discuss experiences with the new regulations MDR and IVDR which were fully implemented from 26 May 2021 and 26 May 2022 respectively. How have they affected the work at the Medical Products Agency and the companies? How have they affected clinical trials? What applies to combination products, when a medicine contains a medical device component (Article 117)? And what does consultation mean for a medical device with medicinal substance? Open to anyone working with and interested in regulatory issues for pharmaceuticals and medical devices.UppsalaSwedenSWEFEB23